Alliance for Cancer Gene Therapy
Rebrand and digital campaign
In 2001, Alliance for Cancer Gene Therapy became a leading non-profit focusing on cancer cell and gene therapy. Unlike other cancer research organizations, the Alliance for Cancer Gene Therapy funds innovative cancer therapy models by recognizing and advancing novel cell and gene therapy studies with the world’s leading cancer researchers. While the organization was well established with legacy donor audiences, it needed to appeal to a new younger, more social media active donor set.
- Strategy & messaging
- Visual identity & standards
- Website with UX/UI design component library
- Email campaign
- Social campaign
- Virtual event digital marketing
Audiences we were talking to
General donors of all age groups and social strata that included cancer patients, caregivers, academia, and the larger biotech and pharma industries.
What we were trying to solve
To breathe new life into the brand and digital ecosystem to open up donor channels and appeal to a broader range of industry partners.
MitoPop has been an enormous asset helping to update and solidify the Alliance for Cancer Gene Therapy brand. Their work is thorough and thoughtful – they provided a 360-degree solution for the next stage for our growth. Unique from most other agencies, MitoPop’s scientific knowledge means that important communications don’t get lost in translation and that complex concepts are explained effectively to a variety of different audiences in the manner they each can digest.
Campaign direction
The design process included a complete rebrand that culminated with a new brand expression that spanned across digital channels, illustrating the hope that this small but impactful organization resonates with patients and researchers alike.
Outcomes
Following a successful launch, their first-ever virtual conference, and the addition of new collaboration partnerships, the Alliance for Cancer Gene Therapy is set up for long-term success to both increase their donor base and continue to drive forward life-saving new therapies.